SolidddVisionTM smartglasses, the first true vision correction for people living with vision loss due to macula ...

Opthea (ASX/NASDAQ:OPT) is a biopharmaceutical company developing novel therapies to address the unmet needs in the treatment of highly prevalent and progressive retinal diseases, including wet ...